ArticleAnnals of the rheumatic diseases2023

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort.

Hongyi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.